|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,038.00 JPY | +0.80% |
|
+4.81% | -6.00% |
| 05-07 | UK's MHRA approves Dawnzera for treatment of familial chylomicronemia syndrome | RE |
| 05-01 | Otsuka's Profit Jumps 15% in Q1 | MT |
| Capitalization | 1,143B 7.31B 6.21B 5.68B 5.37B 9.96B 689B 10.08B 67.36B 26.25B 331B 27.4B 26.83B | P/E ratio 2026 * |
18.1x | P/E ratio 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise value | 874B 5.59B 4.75B 4.35B 4.1B 7.62B 526B 7.71B 51.5B 20.07B 253B 20.95B 20.52B | EV / Sales 2026 * |
0.67x | EV / Sales 2027 * | 0.62x |
| Free-Float |
59.17% | Yield 2026 * |
3.14% | Yield 2027 * | 3.33% |
| 1 day | +0.80% | ||
| 1 week | +4.81% | ||
| Current month | +4.81% | ||
| 1 month | -0.85% | ||
| 3 months | +0.86% | ||
| 6 months | +0.60% | ||
| Current year | -6.00% |
| 1 week | 2,972 |  | 3,077 |
| 1 month | 2,827.5 | | 3,166 |
| Current year | 2,827.5 | | 3,308 |
| 1 year | 2,815 | | 3,353 |
| 3 years | 2,515 | | 3,789 |
| 5 years | 1,845 | | 3,789 |
| 10 years | 1,031.25 | | 3,789 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuji Otsuka
PSD | President | 72 | 31/07/2001 |
Koichi Hisano
CMP | Compliance Officer | - | - |
Minoru Sakurai
CTO | Chief Tech/Sci/R&D Officer | 69 | 28/02/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
Yuji Otsuka
BRD | Director/Board Member | 72 | 29/02/1992 |
| Director/Board Member | 73 | 28/02/1997 | |
| Director/Board Member | 75 | 28/02/2002 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +11.25% | 0.2% | 77 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.80% | +4.81% | +3.86% | +19.14% | 7.31B | |
| -1.04% | -4.52% | -43.83% | -17.70% | 22.89B | |
| -1.50% | -0.07% | -10.90% | +24.11% | 16.88B | |
| -0.68% | +5.54% | +37.03% | +48.02% | 9.4B | |
| -0.66% | +0.46% | -38.63% | -7.51% | 4.33B | |
| +1.62% | +1.19% | +4.98% | +85.89% | 4.2B | |
| -1.95% | +5.34% | +109.91% | +227.52% | 3.8B | |
| +1.00% | +1.00% | +44.17% | +167.25% | 3.65B | |
| +1.20% | +3.69% | -1.07% | -35.69% | 2.13B | |
| +1.02% | +5.41% | +13.31% | +21.74% | 1.99B | |
| Average | -0.01% | +1.74% | +11.88% | +53.28% | 7.66B | |
| Weighted average by Cap. | -0.57% | -0.80% | -4.63% | +30.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,309B 8.37B 7.11B 6.51B 6.15B 11.42B 789B 11.55B 77.18B 30.07B 379B 31.4B 30.74B | 1,372B 8.77B 7.45B 6.82B 6.44B 11.96B 827B 12.1B 80.88B 31.51B 397B 32.9B 32.22B |
| Net income | 63.31B 405M 344M 315M 297M 552M 38.14B 558M 3.73B 1.45B 18.31B 1.52B 1.49B | 68.28B 436M 371M 340M 321M 595M 41.13B 602M 4.02B 1.57B 19.75B 1.64B 1.6B |
| Net Debt | -269B -1.72B -1.46B -1.34B -1.26B -2.35B -162B -2.37B -15.86B -6.18B -77.83B -6.45B -6.32B | -289B -1.85B -1.57B -1.44B -1.36B -2.52B -174B -2.55B -17.05B -6.64B -83.65B -6.93B -6.79B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/05/26 | 3,038.00 ¥ | +0.80% | 2,410,200 |
| 07/05/26 | 3,014.00 ¥ | +5.61% | 4,330,000 |
| 01/05/26 | 2,854.00 ¥ | -1.54% | 2,574,500 |
| 30/04/26 | 2,898.50 ¥ | -2.08% | 2,105,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4768 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition